BCM
PETX

BlueCrest Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

BlueCrest Capital Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,049
Closed -$80K – 1165
2017
Q2 		$80K Buy
+11,049
New +$80K ﹤0.01% 811